Balo language

Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of December 20, 2023

Retrieved on: 
Thursday, November 30, 2023
Health, Health Technology, Other Health, Managed Care, General Health, Clinical Trials, Biotechnology, Annual, Combined, Exercise, Bulletin, Commercial code, Annual general meeting, Email, Balo language, Mass meeting, Audit

In accordance with articles R.225-83 of the French Commercial Code, documents are available for the shareholders from the time the meeting is convened.

Key Points: 
  • In accordance with articles R.225-83 of the French Commercial Code, documents are available for the shareholders from the time the meeting is convened.
  • For any questions relating to the Annual General Meeting of December 20, 2023, shareholders are invited to send an email to [email protected] .
  • The conditions for holding and taking part in this Combined Shareholders’ General Meeting may evolve depending on the health, regulatory and legal requirements in place.
  • In general, shareholders are invited to regularly consult the section dedicated to the General Meeting on the Company's website www.sensorion.com .

Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 20, 2023

Retrieved on: 
Tuesday, May 30, 2023
Biometrics, Radiology, Biotechnology, Pharmaceutical, Oncology, Health, Health Technology, Other Health, Exercise, Balo language, Commercial code, Valbonne, Proxy, Bulletin, Security (finance)

The shareholders of Median Technologies (ALMDT:PA) (Paris:ALMDT) are invited to participate at the Shareholders’ Ordinary and Extraordinary General Meeting which will be held on Tuesday June 20, 2023, at 11:00 AM CEST at PDGB, 174 avenue Victor Hugo – 75116 Paris.

Key Points: 
  • The shareholders of Median Technologies (ALMDT:PA) (Paris:ALMDT) are invited to participate at the Shareholders’ Ordinary and Extraordinary General Meeting which will be held on Tuesday June 20, 2023, at 11:00 AM CEST at PDGB, 174 avenue Victor Hugo – 75116 Paris.
  • All useful information relating to this Shareholders’ General Meeting is regularly updated on Median Technologies’ website.
  • Shareholders may exercise their voting rights before the holding of the Shareholders’ General Meeting, either by returning their postal voting form, or by giving proxy.
  • The detailed procedures relating to the exercise of the right to vote are specified in the notice of the Shareholders’ General Meeting, available here on Median’s website
    The preliminary notice of the Shareholders’ General Meeting has been published in the BALO (Bulletin des annonces légales obligatoires) on May 15, 2023.

Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 24, 2023

Retrieved on: 
Wednesday, May 3, 2023
Biotechnology, Pharmaceutical, Genetics, Health, Exercise, Balo language, Annual, Mass meeting, Commercial code, Annual general meeting, Combined, Email, Bulletin, Security (finance), Audit

In accordance with articles R.225-83 of the French Commercial Code, documents are available for the shareholders from the time the meeting is convened.

Key Points: 
  • In accordance with articles R.225-83 of the French Commercial Code, documents are available for the shareholders from the time the meeting is convened.
  • For any questions relating to the Annual General Meeting of May 24, 2023, shareholders are invited to send an email to [email protected] .
  • The conditions for holding and taking part in this Combined Shareholders’ General Meeting may evolve depending on the health, regulatory and legal requirements in place.
  • In general, shareholders are invited to regularly consult the section dedicated to the General Meeting on the Company's website www.sensorion.com .